John Del Rowe

578 total citations
14 papers, 436 citations indexed

About

John Del Rowe is a scholar working on Pulmonary and Respiratory Medicine, Genetics and Molecular Biology. According to data from OpenAlex, John Del Rowe has authored 14 papers receiving a total of 436 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pulmonary and Respiratory Medicine, 5 papers in Genetics and 4 papers in Molecular Biology. Recurrent topics in John Del Rowe's work include Glioma Diagnosis and Treatment (5 papers), Cancer therapeutics and mechanisms (3 papers) and Brain Metastases and Treatment (3 papers). John Del Rowe is often cited by papers focused on Glioma Diagnosis and Treatment (5 papers), Cancer therapeutics and mechanisms (3 papers) and Brain Metastases and Treatment (3 papers). John Del Rowe collaborates with scholars based in United States, Canada and United Kingdom. John Del Rowe's co-authors include Charles Scott, Jay S. Loeffler, Christopher G. Schultz, Robert W. Kline, Robert P. Dinapoli, Lawrence B. Marks, Kyu H. Shin, Luís Souhami, Edward Shaw and Jean-Paul Bahary and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics and Radiation Research.

In The Last Decade

John Del Rowe

14 papers receiving 423 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Del Rowe United States 9 210 206 102 99 95 14 436
Nancy Riese United States 9 162 0.8× 214 1.0× 63 0.6× 45 0.5× 40 0.4× 11 347
Kai Eichhorn Germany 7 151 0.7× 67 0.3× 48 0.5× 121 1.2× 73 0.8× 13 447
Aditya Shenoy United Kingdom 9 169 0.8× 294 1.4× 52 0.5× 189 1.9× 108 1.1× 11 515
Eduardas Aleknavičius Lithuania 10 78 0.4× 54 0.3× 46 0.5× 94 0.9× 101 1.1× 33 386
Daniele Scartoni Italy 9 212 1.0× 48 0.2× 37 0.4× 44 0.4× 76 0.8× 45 351
Michaelyn A. Page United States 10 189 0.9× 295 1.4× 66 0.6× 78 0.8× 68 0.7× 15 407
Mitsuyuki Abe Japan 11 179 0.9× 32 0.2× 19 0.2× 74 0.7× 69 0.7× 18 417
Jianfeng Wu China 12 107 0.5× 52 0.3× 84 0.8× 214 2.2× 75 0.8× 43 520
Daniel H. Y. Shen Taiwan 11 98 0.5× 50 0.2× 39 0.4× 152 1.5× 64 0.7× 19 498
K H Kärcher Austria 6 141 0.7× 34 0.2× 24 0.2× 31 0.3× 54 0.6× 11 296

Countries citing papers authored by John Del Rowe

Since Specialization
Citations

This map shows the geographic impact of John Del Rowe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Del Rowe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Del Rowe more than expected).

Fields of papers citing papers by John Del Rowe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Del Rowe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Del Rowe. The network helps show where John Del Rowe may publish in the future.

Co-authorship network of co-authors of John Del Rowe

This figure shows the co-authorship network connecting the top 25 collaborators of John Del Rowe. A scholar is included among the top collaborators of John Del Rowe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Del Rowe. John Del Rowe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Henkin, Robert E., John Del Rowe, Perry W. Grigsby, et al.. (2011). ACR–ASTRO Practice Guideline for the Performance of Therapy With Unsealed Radiopharmaceutical Sources. Clinical Nuclear Medicine. 36(8). e72–e80. 2 indexed citations
2.
Casper, Diana, Wainwright Jaggernauth, Peter Werner, et al.. (2000). Acetaminophen Selectively Reduces Glioma Cell Growth and Increases Radiosensitivity in Culture. Journal of Neuro-Oncology. 46(3). 215–229. 23 indexed citations
3.
Rowe, John Del, Charles Scott, Maria Werner‐Wasik, et al.. (2000). Single-Arm, Open-Label Phase II Study of Intravenously Administered Tirapazamine and Radiation Therapy for Glioblastoma Multiforme. Journal of Clinical Oncology. 18(6). 1254–1259. 76 indexed citations
4.
Rowe, John Del, Jacqueline A. Bello, Robin J. Mitnick, et al.. (1999). Accelerated regression of brain metastases in patients receiving whole brain radiation and the topoisomerase II inhibitor, lucanthone. International Journal of Radiation Oncology*Biology*Physics. 43(1). 89–93. 33 indexed citations
5.
Rowe, John Del, Clare L. Scott, Maria Werner‐Wasik, et al.. (1998). A single-arm open label phase II study of intravenously administered tirapazamine for glioblastoma multiforme (GBM)—An RTOG study. International Journal of Radiation Oncology*Biology*Physics. 42(1). 266–266. 1 indexed citations
6.
Shaw, Edward, Charles Scott, Luís Souhami, et al.. (1996). Radiosurgery for the treatment of previously irradiated recurrent primary brain tumors and brain metastases: Initial report of radiation therapy oncology group protocol 90-05. International Journal of Radiation Oncology*Biology*Physics. 34(3). 647–654. 203 indexed citations
7.
Brasacchio, R.A., Louis S. Constine, Abrão Rapoport, et al.. (1996). 25 Dose escalation of consolidation radiation therapy (involved field) following autologous bone marrow transplant for recurrent Hodgkin's disease and lymphoma. International Journal of Radiation Oncology*Biology*Physics. 36(1). 171–171. 8 indexed citations
8.
Fontenla, Doracy P., et al.. (1995). Three‐dimensional external‐beam radiation treatment planning and real‐time dose verification of pituitary adenoma: Clinical and physical considerations. Radiation Oncology Investigations. 3(3). 141–148. 3 indexed citations
9.
Rowe, John Del, et al.. (1994). Altered RNA turnover in carcinogenesis. Molecular and Chemical Neuropathology. 21(2-3). 353–368. 23 indexed citations
10.
Mun, Chi‐Woong, John Del Rowe, Margarita Sandigursky, Kenneth W. Minton, & William A. Franklin. (1994). DNA Deoxyribophosphodiesterase and an Activity That Cleaves DNA Containing Thymine Glycol Adducts in Deinococcus radiodurans. Radiation Research. 138(2). 282–282. 14 indexed citations
11.
Pelton, James, John Del Rowe, John W. Bolen, et al.. (1986). Fast Neutron Radiotherapy for Soft Tissue Sarcomas University of Washington Experience and Review of the Worldʼs Literature. American Journal of Clinical Oncology. 9(5). 397–400. 9 indexed citations
12.
Scott, R.S. & John Del Rowe. (1986). A Transient Hypotensive Episode (Bezold-Jarisch Effect) Occurring in a Patient Treated With Microwave Hyperthermia. American Journal of Clinical Oncology. 9(2). 170–172. 6 indexed citations
13.
Pelton, James, John Del Rowe, John W. Bolen, et al.. (1984). Fast neutron radiotherapy for soft tissue sarcomas: University of Washington experience and review of the world's literature. International Journal of Radiation Oncology*Biology*Physics. 10. 164–164. 1 indexed citations
14.
Cooper, Jay S., John Del Rowe, & Joseph Newall. (1983). Regional stage IV carcinoma of the nasopharynx treated by aggressive radiotherapy. International Journal of Radiation Oncology*Biology*Physics. 9(11). 1737–1745. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026